Under the leadership of Sidonie Golombowski-Daffner, Chairperson and President, the Executive Leadership Team of AAA is responsible for overseeing business operations. Each member of the Executive Leadership Team represents a global function.

Executive Leadership Team

Sidonie Golombowski-Daffner, Ph.D., Chairperson and President. Sidonie Golombowski-Daffner was appointed Chairperson and President of Advanced Accelerator Applications (AAA), a Novartis company in October 2019. Prior to this, Sidonie was General Manager, Novartis Pharma GmbH Nürnberg and Country President Germany since 2017. In this capacity, she was also a member of the Supervisory Boards of Novartis Deutschland GmbH and Novartis Pharma GmbH, Country Executive Committee, Innovative Medicines Committee and Pharma Leadership Team Region Europe. As Country President Germany, Sidonie oversaw 7,500 associates across 12 sites, generating $3.9 billion in sales. During her tenure as General Manager of Novartis Pharma Germany, she led the marketing of products in Rare Diseases, Immunology & Dermatology, Neuroscience, Cardiology, Respiratory and Ophthalmology. Under her leadership, the team launched the first Cell and Gene therapy in the Pharma Division, Luxturna, for Ophthalmology. From 2014 to 2017, Sidonie served as Novartis Worldwide Franchise Head, Respiratory in Basel. She first joined Novartis in 2011, as Head of Primary Care for Germany. Prior to this, Sidonie spent 10 years at Sanofi and its predecessor companies, Sanofi-Aventis and Sanofi-Synthelabo in a variety of leadership positions with increasing responsibility across the pharmaceutical and generic sectors in Germany, at the corporate headquarters in France, and in the Asia-Pacific region. Sidonie first started her career as a management consultant at Roland Berger, where she spent five years advising pharmaceutical clients in the US, Europe, Russia and Japan. Sidonie holds a Ph.D. in Neuroscience from Ludwig Maximilian University of Munich (Germany) and has additional qualifications in Business Administration.